4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-20-063476
CFO & COO sold 1,250 shares at $25.00 ($31,250)
- CFO & COO acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GRAY MICHAEL · CFO & COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-11 | Exercise or conversion : show line 1 in the form | +1,250 | $4.92 | $6,150 | 1,250 | D |
| 2020-12-11 | Sale : show line 2 in the form | −1,250 | $25.00 | $31,250 | 0 | D |
| Open-market sales · 1,250 sh · avg $25.00 · $31,250 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-11 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,250 | 223,059 | D |
Loading xslF345X03/doc4.xml…